Deep Tech Startups

OceanSync builds marine data infrastructure that captures high-frequency vessel data via its onboard Vortex Edge system and combines it with edge computing and analytics to deliver voyage analytics, predictive roll-motion risk tools, forecasting models, and resale datasets. It serves marine transportation, defence and government, offshore surveying, and port operations customers for safer, more efficient ocean operations.

1 investor

A company developing technology for forest management and climate protection. The team combines expertise in forestry, engineering, climate science, and operations to build software that supports better forest decision-making.

1 investor

OCI Vacuum Microengineering manufactures electron spectroscopy instruments and related analytical equipment for materials research across scientific laboratories. The company specializes in nano-scale surface characterization and elemental analysis, with recent development efforts focused on battery testing systems and energy harvesting technologies.

1 investor

Octarine Bio is a synthetic biology platform company that engineers microorganisms to produce bio-based, low-impact ingredients and materials to replace unsustainable synthetic chemical processes across industries including pharmaceuticals, chemicals, food, and energy. Founded in 2018 based on research from Danish universities, the company applies precision fermentation and enzymatic enhancement to develop commercial-scale bio-manufacturing solutions.

1 investor

Octeract is a consultancy of PhD mathematicians and decision scientists that builds custom AI, mathematical modelling, and optimisation solutions to turn client data into forecasts and optimal decisions. It serves organisations across industries facing prediction and optimisation problems, such as logistics route optimisation.

1 investor

Ocutheia offers biotechnology consulting services with expert biotechnologists providing tailored solutions to clients.

1 investor

OD-OS manufactures the Navilas® 577s, a navigated retina laser system for ophthalmologic treatments including photocoagulation, microsecond pulsing therapy, and laser trabeculoplasty. The system serves retinal specialists and clinics performing precision laser treatments for conditions such as diabetic macular edema, central serous chorioretinopathy, and glaucoma.

1 investor

Odin Dynamics develops technology aimed at supporting global deterrence and defense.

1 investor

Odyssey is an AI lab developing general-purpose world models that learn from multimodal interactions with the physical world. The company creates systems capable of physical simulation and multi-agent interaction for research and applied purposes.

1 investor

Odyssey develops space-based compute infrastructure, launching orbital supercomputers designed to deliver high-density, energy-efficient computing for AI workloads. The company builds a constellation of purpose-built space vehicles that operate as a distributed compute network, enabling large-scale AI training, inference, and specialized scientific workloads that cannot be accommodated by Earth-based infrastructure.

1 investor

OE Solutions manufactures optoelectronic transceiver solutions for broadband wireless and wireline networks, serving applications including wireless backhaul, MANs, LANs, SANs, and PONs. The company is headquartered in South Korea and supplies systems integrators globally.

1 investor

OI Analytical manufactures analytical instruments for laboratory use, enabling testing across environmental, food, fuel, and water sectors. The company adapts industry standard methods into its instruments to help customers generate accurate data for regulated testing.

1 investor

Olam Labs builds multiplayer game environments — such as no-limit Texas hold'em, Risk-style conquest, Codenames-style word deduction, and market simulations — to study how AI agents negotiate, socialize, and compete alongside humans. It also runs large-scale internal simulations with hundreds of concurrent agents and publishes notable research runs.

1 investor

Maker of explosion-proof industrial gas-detection hardware, including photoionization, electrochemical, catalytic, and infrared gas sensors, VOC detectors, audible/visual alarms, and a wearable safety watch with location and emergency calling. Devices communicate wirelessly and upload monitoring data to an IoT platform.

1 investor

Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.

1 investor

OliKrom develops color-intelligence materials with programmed color-change properties for industrial applications, including detection of overheating, impacts, hydrogen leaks, corrosion, wear indicators, anti-counterfeiting solutions, and adaptive coatings against solar heat. Founded in 2014, it serves large industrial companies in France and internationally with materials-science solutions supporting eco-innovation and smart-city development.

1 investor

Olive Capital is a seed-stage venture capital firm that invests in founders building in synthetic biology, software, and emerging platforms.

1 investor

OMTX develops machine learning tools and datasets for drug discovery, helping researchers globally identify new therapeutic mechanisms of action and accelerate the development of medicines.

1 investor

Omni3D manufactures large-format industrial 3D printers for production and tooling applications in aerospace, automotive, defense, and maintenance sectors. The company offers open-system printing solutions with industry-grade components and support services to businesses across Europe and globally.

1 investor

OmniBio develops biologically-inspired AI models for autonomous robots and machines used in manufacturing, agriculture, and construction. The technology enables robots to learn and adapt in dynamic environments without traditional sensors or connectivity.

1 investor

OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.

1 investor

Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.

1 investor

Omnispace develops satellite-based connectivity that delivers next-generation mobile service, spectrum flexibility, and compute directly to mobile devices on Earth. Following a merger with Lynk, the company launched Elveo Mobile to provide this direct-to-device connectivity.

1 investor

Order-made Medical Research Inc. (OMR) develops antibody drug discovery technologies, including its LIMAXYS platform for generating antibodies against multi-pass transmembrane targets, plus the INTAB and MUTAB platforms for internalizing and disease-specific mutation antibodies. The company aims to create new antibody-based therapies for hard-to-treat cancers, autoimmune diseases, and neurodegenerative disorders.

1 investor